Haas Jason 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Haas Jason
Director
Transactions
- Award
Common Stock
2023-06-09+1,142→ 4,145 total - Award
Non-Qualified Stock Option (right to buy)
2023-06-09+5,461→ 5,461 totalExercise: $73.76Exp: 2033-06-09→ Common Stock (5,461 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.